MBBS and PhD in Biomedical Sciences- Molecular Biology with special interest in the modular composition of gene regulation and the interface of Molecular Biology and Medicine.
Melanoma Patient Advocacy, with focus on patient-centric clinical research, innovative clinical trial designs and alternative drug development models (like MAPPS) and sustainable healthcare innovation.
To Serve PatientsAmgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.
To systematically and pragmatically address the problems European Melanoma patients are facing in an independent, constructive, result-orientated and collaborative manner. MPNE Principles 1. PATIENTS FIRST. MPNE's works to improve the lives of Melanoma patients. While our main focus and expertise is Melanoma, we believe in solutions for ALL patients and not for one group at the expense of others. 2. SOLUTIONS, NOT PROBLEMS. Melanoma patients need solutions. MPNE's approach is therefore result-orientated: we contribute and drive solutions for Melanoma patients. 3. DATA, NOT OPINIONS. MPNE's advocacy positions are based on evidence and data, not on single opinions. 4. PROACTIVITY Assuming responsibility is an important part of our approach to advocacy. Because no one is more concerned about Melanoma than Melanoma patients.Access to prevention, early detection and effective treatment in Melanoma across Europe.
WECAN Science Academy - Scientific training for Patient Advocates.
Online Advocacy – Social Media & Valuable Tools
Cancer and COVID-19 - "Short-Term Reality, Long-Term Vision"
Podcast: How to Make Patient Involvement Sustainable Throughout Medicines Development
13 Jan 2019